Teva Awarded Judgment on the Pleadings in N.Y. Generic Contraceptive Case



DOCUMENTS
  • Order


NEW YORK — A New York federal judge has awarded Teva Pharmaceuticals USA Inc. judgment on the pleadings in an oral contraceptive action, finding the claims are preempted because it was impossible for the defendant to redesign its generic drug while complying with federal law.

In an April 14 order, Judge Alvin K. Hellerstein of the U.S. District Court for the Southern District of New York.

Emely Montero took Teva’s generic equivalent of Janssen Pharmaceuticals’ Ortho Tri-Cyclen Lo — Tri-Lo Sprintec — from February 2010 to August 2016. Montero alleges the oral contraceptive caused her to suffer life-threatening blood …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Midwest Asbestos Litigation

December 02, 2020 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin’s Webinar Series: Surgical Stapler Litigation

January 14, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS